Circulating regulatory T cells are reduced in obesity and may identify subjects at increased metabolic and cardiovascular risk.
about
The Immune Landscape in Nonalcoholic Steatohepatitis.Lymphocyte roles in metabolic dysfunction: of men and miceObesity-driven disruption of haematopoiesis and the bone marrow niche.Distinct Blood and Visceral Adipose Tissue Regulatory T Cell and Innate Lymphocyte Profiles Characterize Obesity and Colorectal Cancer.Role of T cells in malnutrition and obesity.Metabolic control of regulatory T cell development and function.Lack of correlation between Treg quantification assays in inflammatory bowel disease patientsCrosstalk between intestinal microbiota, adipose tissue and skeletal muscle as an early event in systemic low-grade inflammation and the development of obesity and diabetes.Peripheral mononuclear blood cells contribute to the obesity-associated inflammatory state independently of glycemic status: involvement of the novel proinflammatory adipokines chemerin, chitinase-3-like protein 1, lipocalin-2 and osteopontin.Immune regulation of metabolic homeostasis in health and disease.Female PAPP-A knockout mice are resistant to metabolic dysfunction induced by high-fat/high-sucrose feeding at middle age.Impact of Helicobacter pylori Immunoglobulin G Levels and Atrophic Gastritis Status on Risk of Metabolic SyndromeRegulatory T Cells, Frailty, and Immune Activation in Men Who Have Sex With Men in the Multicenter AIDS Cohort StudyMetabolic Syndrome after Hematopoietic Cell Transplantation: At the Intersection of Treatment Toxicity and Immune Dysfunction.Adipose tissue inflammation in glucose metabolism.Peripheral blood leucocyte subclasses as potential biomarkers of adipose tissue inflammation and obesity subphenotypes in humans.Modifiable environmental factors in multiple sclerosis.The complex immunological and inflammatory network of adipose tissue in obesity.Pathological conditions re-shape physiological Tregs into pathological Tregs.The role of immune cells in metabolism-related liver inflammation and development of non-alcoholic steatohepatitis (NASH).Higher Body Mass Index Is Associated With Greater Proportions of Effector CD8+ T Cells Expressing CD57 in Women Living With HIV.Innate lymphoid cells as novel regulators of obesity and its-associated metabolic dysfunction.Liver inflammation and fibrosis.Nutritional effects on T-cell immunometabolism.Immunometabolism of human autoimmune diseases: from metabolites to extracellular vesicles.The Cell Surface Markers Expression in Postmenopausal Women and Relation to Obesity and Bone Status.Adaptive Immunity and Metabolic Health: Harmony Becomes Dissonant in Obesity and Aging.High fat diet and leptin promote tumor progression by inducing myeloid-derived suppressor cells.Lipodystrophy and obesity are associated with decreased number of T cells with regulatory function and pro-inflammatory macrophage phenotype.PPAR-γ agonist ameliorates liver pathology accompanied by increasing regulatory B and T cells in high-fat-diet mice.Adipokines and inflammation: is it a question of weight?T Cell Populations and Functions Are Altered in Human Obesity and Type 2 Diabetes.Anti-inflammatory effects of heat-killed Lactobacillus plantarum L-137 on cardiac and adipose tissue in rats with metabolic syndrome.Decreased circulating T regulatory lymphocytes in obese patients undergoing bariatric surgery.Sex Differences in Adipose Tissue CD8+ T Cells and Regulatory T Cells in Middle-Aged Mice.Emerging Functions of Regulatory T Cells in Tissue Homeostasis.Obesity, Fat Mass and Immune System: Role for Leptin.Insights into the Mechanisms That May Clarify Obesity as a Risk Factor for Multiple Sclerosis.Regulation of Energy Expenditure and Brown/Beige Thermogenic Activity by Interleukins: New Roles for Old Actors
P2860
Q26747323-EF67EA5D-21B4-49BA-9FE6-3A3078119692Q27687298-E41EEEC7-0853-47F4-89B0-33B3FEDF8834Q30367783-E24D8BE0-4261-46C4-883C-81892239FB56Q33780586-AECD8A3F-2AA3-4F38-A56B-659F3B9F85B1Q34023205-FA1BB61B-391E-48C5-8846-1FDCE5C1B658Q34790948-D0CB2AFD-F541-4671-8F97-A0990EBFADCAQ35188631-64929456-6210-4C34-A86A-63F664DCC1D1Q35373283-F1C34B86-E63F-4E54-BBC0-BD3DB0C23D9CQ35396061-01CC6F3E-5669-46C3-B18F-1B9B5E4C11B7Q35450500-DB83D63E-C9CE-4BEA-9044-9D2AC4E02F9EQ35582678-9A06BBC0-F0DB-4792-B628-D7296DD5647DQ36194202-140278BA-2FA7-4BFD-A301-0B2C9A2872A6Q36573561-AEEBFC27-9463-4DB6-9146-83E20EE4D939Q36999204-4AE45BB0-7F11-49C2-A95B-6784539A57CFQ38139293-9F05DE77-7CA2-4A3C-A744-D44026A5B3BCQ38164099-1BB0ED95-F7EE-4384-A66A-371CBB52CFEFQ38269727-AE1C4552-E4F4-488E-852E-0EA6D45B316DQ38578953-F67D67CD-6C12-428A-B408-88BDE433FD36Q38654764-EB831378-1178-4EE7-9A0F-7ECDEBA6DD8EQ38723669-5C417B8D-180D-4807-A57E-3A7CC3377E14Q38741619-2C8044E5-449E-4606-83AE-3255DFBBDE07Q38763067-F722987C-CDF6-4F00-840E-124B4F043331Q39065620-6A3DACA5-467D-4F3A-BFC6-511EEA874AE9Q39068014-B963ED93-5F9F-44E5-8D96-0202EEE4EDD4Q39397975-89F46748-8308-4EEC-BF51-9D9A4FB5F692Q41338463-229056EF-26AF-4F3C-96E1-45BFD640AEC7Q47670316-F7375F0E-03F9-4CA9-BAFF-0F4577DC9AF9Q49973501-452782B4-271B-481D-BAFF-3AE4025A2F6AQ50201499-346D813F-12E2-43A9-AAAA-5B3B58E160FAQ51157271-E60FA802-FB45-4DBD-BF46-39091C844998Q51766923-D9852376-8585-44F2-B450-3AAB1DBE5AF6Q51813073-AA9B6089-C021-4EF0-8BBA-9986BCCF5FF2Q54974087-A56DF05B-2E73-4D60-8EB4-52D9A32D50A3Q55032087-0B9607AD-FBA3-4084-AFEA-8515A0C616ABQ55075666-B1BEEB9E-CAE8-401D-BAC1-C7000C531B72Q55077356-E787C645-196D-47A1-8C35-F54A96A83574Q55081066-C0F2FE6D-CB40-4C72-8CC4-6820C8832EFBQ55100058-86495B3C-7727-442E-8DA5-76492FC6768FQ58692657-37563DA9-9A33-4ECD-A20E-9DB8EC1B98B1
P2860
Circulating regulatory T cells are reduced in obesity and may identify subjects at increased metabolic and cardiovascular risk.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Circulating regulatory T cells ...... bolic and cardiovascular risk.
@en
Circulating regulatory T cells ...... bolic and cardiovascular risk.
@nl
type
label
Circulating regulatory T cells ...... bolic and cardiovascular risk.
@en
Circulating regulatory T cells ...... bolic and cardiovascular risk.
@nl
prefLabel
Circulating regulatory T cells ...... bolic and cardiovascular risk.
@en
Circulating regulatory T cells ...... bolic and cardiovascular risk.
@nl
P2093
P2860
P356
P1433
P1476
Circulating regulatory T cells ...... abolic and cardiovascular risk
@en
P2093
Christoph Eberle
Frauke Czepluch
Gerd Hasenfuss
Gunnar Brandhorst
Joachim Riggert
Michael Oellerich
Nana-Maria Wagner
Sebastian Herzberg
Stavros Konstantinides
Vivien Faustin
P2860
P304
P356
10.1002/OBY.20087
P577
2013-03-01T00:00:00Z